Efficient Recovery of HLA Class I Expression in Human Tumor Cells After Beta2-Microglobulin Gene Transfer Using Adenoviral Vector: Implications for Cancer Immunotherapy-Reference-Cited by-同舟云学术

Efficient Recovery of HLA Class I Expression in Human Tumor Cells After Beta2-Microglobulin Gene Transfer Using Adenoviral Vector: Implications for Cancer Immunotherapy

Published:2009-08 Issue:2 Volume:70 Page:125-135
ISSN:0300-9475
Container-title:Scandinavian Journal of Immunology
language:en
Short-container-title:

Author:

del Campo A. B.,Aptsiauri N.,Méndez R.,Zinchenko S.,Vales Á.,Paschen A.,Ward S.,Ruiz-Cabello F.,González-Aseguinolaza G.,Garrido F.

Publisher

Wiley

Subject

Immunology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-3083.2009.02276.x/fullpdf

Reference39 articles.

1. Natural selection of tumor variants in the generation of “tumor escape” phenotypes;Khong;Nat Immunol,2002

2. Natural history of HLA expression during tumor development;Garrido;Immunol Today,1993

3. MHC antigens and tumor escape from immune surveillance;Garrido;Adv Cancer Res,2001

4. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours;Garrido;Immunol Today,1997

5. Tumor antigens recognized by T cells;Boon;Immunol Today,1997

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic and molecular alterations associated with primary resistance to immune checkpoint inhibitors;Cancer Immunology, Immunotherapy;2024-09-13

2. MHC/HLA Class-I Loss and Cancer Immune Escape;The Major Histocompatibility Complex (MHC/ HLA) in Medicine;2024

3. Strategies to overcome low MHC-I expression in paediatric and adult tumours;Immunotherapy Advances;2023-12-11

4. A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours;Frontiers in Pharmacology;2023-05-15

5. A Novel Tongue Squamous Cell Carcinoma Cell Line Escapes from Immune Recognition due to Genetic Alterations in HLA Class I Complex;Cells;2022-12-22